| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.037 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |